Clinical Trial Update: Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Alfimeprase for thrombolysis in acute peripheral arterial occlusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Thrombosis
• Peripheral Artery Disease
• Peripheral Vascular Disease

Drugs mentioned

• Alfimeprase (alfimeprase)

Snippet

Sponsor: ARCA Biopharma, Inc. | Conditions: Arterial Occlusive Diseases, Peripheral Vascular Diseases | Phase 2 | Status: COMPLETED